73.92 USD
+1.81 (+2.51%)
73.92 USD
0 (0%)
Overall DXCM gets a fundamental rating of 7 out of 10. We evaluated DXCM against 186 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DXCM could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year DXCM was profitable.
- DXCM had a positive operating cash flow in the past year.
- DXCM had positive earnings in each of the past 5 years.
- Each year in the past 5 years DXCM had a positive operating cash flow.
1.2 Ratios
- DXCM has a Return On Assets of 9.61%. This is amongst the best in the industry. DXCM outperforms 93.01% of its industry peers.
- DXCM has a better Return On Equity (26.44%) than 97.31% of its industry peers.
- With an excellent Return On Invested Capital value of 15.72%, DXCM belongs to the best of the industry, outperforming 95.70% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.84%.
- The last Return On Invested Capital (15.72%) for DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- DXCM has a Profit Margin of 15.96%. This is amongst the best in the industry. DXCM outperforms 92.47% of its industry peers.
- DXCM's Profit Margin has improved in the last couple of years.
- DXCM has a Operating Margin of 18.41%. This is amongst the best in the industry. DXCM outperforms 90.32% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- The Gross Margin of DXCM (60.20%) is better than 61.29% of its industry peers.
- In the last couple of years the Gross Margin of DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DXCM is still creating some value.
- Compared to 1 year ago, DXCM has more shares outstanding
- DXCM has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, DXCM has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.21 indicates that DXCM is not in any danger for bankruptcy at the moment.
- The Altman-Z score of DXCM (5.21) is better than 77.42% of its industry peers.
- DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as DXCM would need 2.36 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.36, DXCM belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
- DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.47, DXCM is in line with its industry, outperforming 43.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.21 |
ROIC/WACC1.64
WACC9.6%
2.3 Liquidity
- A Current Ratio of 1.56 indicates that DXCM should not have too much problems paying its short term obligations.
- DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 71.51% of its industry peers.
- DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a worse Quick ratio (1.38) than 60.22% of its industry peers.
- The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.41% over the past year.
- The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- Based on estimates for the next years, DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.05% on average per year.
- Based on estimates for the next years, DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.28% on average per year.
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue Next Year15.38%
Revenue Next 2Y14.05%
Revenue Next 3Y13.59%
Revenue Next 5Y13.28%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- DXCM is valuated quite expensively with a Price/Earnings ratio of 39.74.
- 72.04% of the companies in the same industry are more expensive than DXCM, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.32. DXCM is valued slightly more expensive when compared to this.
- The Price/Forward Earnings ratio is 29.37, which means the current valuation is very expensive for DXCM.
- DXCM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 73.66% of the companies in the same industry.
- DXCM is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.74 | ||
| Fwd PE | 29.37 |
4.2 Price Multiples
- 73.66% of the companies in the same industry are more expensive than DXCM, based on the Enterprise Value to EBITDA ratio.
- DXCM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DXCM is cheaper than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.15 | ||
| EV/EBITDA | 24 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DXCM may justify a higher PE ratio.
- A more expensive valuation may be justified as DXCM's earnings are expected to grow with 22.59% in the coming years.
PEG (NY)1.45
PEG (5Y)1.36
EPS Next 2Y23.51%
EPS Next 3Y22.59%
5. Dividend
5.1 Amount
- No dividends for DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
73.92
+1.81 (+2.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-12 2026-02-12/amc
Inst Owners99.77%
Inst Owner Change0.24%
Ins Owners0.19%
Ins Owner Change0.57%
Market Cap28.83B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.95
Price Target87.62 (18.53%)
Short Float %3.71%
Short Ratio2.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-0.5%
PT rev (3m)-16.15%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)-4.84%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.74 | ||
| Fwd PE | 29.37 | ||
| P/S | 6.38 | ||
| P/FCF | 27.15 | ||
| P/OCF | 19.91 | ||
| P/B | 10.58 | ||
| P/tB | 10.99 | ||
| EV/EBITDA | 24 |
EPS(TTM)1.86
EY2.52%
EPS(NY)2.52
Fwd EY3.41%
FCF(TTM)2.72
FCFY3.68%
OCF(TTM)3.71
OCFY5.02%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.45
PEG (5Y)1.36
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.21 |
F-Score5
WACC9.6%
ROIC/WACC1.64
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.38%
Revenue Next 2Y14.05%
Revenue Next 3Y13.59%
Revenue Next 5Y13.28%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.34%
EBIT Next 5Y30.77%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 39.74 and the Price/Book (PB) ratio is 10.58.